An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways
2011 · Leukemia · 172 citations
https://doi.org/10.1038/leu.2011.273
M
Meng Lv
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
301
Papers
3.7K
Citations
31
h-index
84
i10-index
Meng Lv is an academic researcher from Ophthalmology Associates (United States). The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Myeloid Leukemia Research & Acute Lymphoblastic Leukemia research. The author has an h-index of 31, co-authored 256 publications.
ORCID: 0000-0001-6625-9523Papers by this author
worksMyeloid-derived suppressor cells in hematological malignancies: friends or foes
2019 · Journal of Hematology & Oncology · 120 citations
https://doi.org/10.1186/s13045-019-0797-3
miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K/Akt and p53 in Immune Thrombocytopenia
2020 · Molecular Therapy — Nucleic Acids · 45 citations
https://doi.org/10.1016/j.omtn.2020.04.013
New drug approvals for 2021: Synthesis and clinical applications
2022 · European Journal of Medicinal Chemistry · 44 citations
https://doi.org/10.1016/j.ejmech.2022.114898
Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease
2015 · Annals of Hematology · 28 citations
https://doi.org/10.1007/s00277-015-2414-z
Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes
2022 · Journal of Translational Medicine · 18 citations
https://doi.org/10.1186/s12967-022-03354-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat